Description
ProStrakan Reports Further Strong Progress in Preclose Update – 1/8/2008 ProStrakan Group plc today issues a business and trading update for the 12 months ended 31 December, 2007, ahead of the close period preceding the publication of the Group's Preliminary Results, planned for March 13, 2008. Click to view more Positive US Phase III Interim Data on Rapinyl™ Released by Endo Pharmaceuticals Incorporated - 12/17/2007 Galashiels, Scotland, 17 December, 2007 – ProStrakan Group plc (LSE: PSK), the international specialty pharmaceutical company, announces that Endo Pharmaceuticals Incorporated (“Endo”) has today reported positive results from an interim statistical analysis of its US Phase III, placebo-controlled, double-blind trial of Rapinyl™ (announcement attached). Rapinyl™ is a fast-dissolving tablet for sublingual administration of fentanyl intended for the treatment of breakthrough cancer pain. ProStrakan has in-licensed the exclusive rights to develop and market Rapinyl™ in Europe from Orexo AB, while Endo has in-licensed the rights for North America. Click to view more Peter Allen Takes Up Position as Chairman of ProStrakan - 12/7/2007 ProStrakan Group plc, the international specialty pharmaceutical company, announced on October 30, 2007 that its co-founder and Chairman, Harry Stratford OBE, had informed the Board of his intention to retire as Chairman at the end of 2007. The Company also announced that Peter Allen, a Non-Executive Director since 2005, had accepted the Board’s invitation to replace him. ProStrakan announces that the formal handover took place at the Company’s Board meeting, which was held yesterday (December 6, 2007). Click to view more ProStrakan Receives Approval for Adcal-D Dissolve™ - 12/3/2007 ProStrakan Group plc (LSE: PSK), the international specialty pharmaceutical company, today announces that it has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for the launch in the UK of Adcal-D
Fact sheet
Products & services
Similar companies nearby
-
Growthstream LLC
Distance: 0.8 MiPO BOX 342
07931 Far Hills -
Tim Peters and Company, Inc.
Distance: 2.6 MiPO Box 370
07977-0370 Peapack -
Healthcare Institute of NJ
Distance: 2.8 Mi95 Corporate Dr
08807 Bridgewater -
Doxil
Distance: 6.1 Mi430 Route 22 E
08807-0914 Bridgewater -
Wolters Kluwer Pharma Solutions
Distance: 6.4 Mi400 Somerset Corporate Blvd Ste 600
08807-2867 Bridgewater